Menu
Back to Journals » Biologics: Targets and Therapy » Volume 6
Review
First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 15,361 | Dovepress* | 11,493+ | 2,534 | 14,027 | |
| PubMed Central* | 3,868 | 1,185 | 5,053 | ||
| Totals | 15,361 | 3,719 | 19,080 | ||
|
*Since 25 September 2012 +Since July 2016 |
|||||
View citations on PubMed Central and Google Scholar